Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
GSK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
reuters.com
8 hours ago
prnewswire.com
10 hours ago
zacks.com
12 hours ago
globenewswire.com
14 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
+16%
1.26
vs 1.09
Q4.23
+13%
0.72
vs 0.64
Q1.24
+21%
1.09
vs 0.9
Q2.24
+12%
1.09
vs 0.97
Q3.24
+1%
1.27
vs 1.26
Q4.24
-18%
0.59
vs 0.72
Q1.25
+4%
1.13
vs 1.09
Q2.25
+13%
1.23
vs 1.09
Q3.25
-21%
1
vs 1.27
Q4.25
-5%
0.56
vs 0.59
Sales Growth
YoY
Current
Estimates
Q3.23
+4%
8.1B vs 7.8B
Q4.23
+9%
8.1B vs 7.4B
Q1.24
+6%
7.4B vs 7B
Q2.24
+10%
7.9B vs 7.2B
Q3.24
-2%
8B vs 8.1B
Q4.24
+1%
8.1B vs 8.1B
Q1.25
+2%
7.5B vs 7.4B
Q2.25
+1%
8B vs 7.9B
Q3.25
+36%
10.9B vs 8B
Q4.25
+35%
10.9B vs 8.1B
Return on Equity
QoQ
Q1.23
+13%
0.13
vs 0.14
Q2.23
+13%
0.13
vs 0.13
Q3.23
+11%
0.11
vs 0.13
Q4.23
+3%
0.03
vs 0.11
Q1.24
+8%
0.08
vs 0.03
Q2.24
+8%
0.08
vs 0.08
Q3.24
0%
-0.00
vs 0.08
Q4.24
+3%
0.03
vs -0.00
Q1.25
+11%
0.11
vs 0.03
Q2.25
+10%
0.1
vs 0.11
Institutionnal Ownership
QoQ
Q1.23
839
839
vs 849
-1%
Q2.23
845
845
vs 839
1%
Q3.23
871
871
vs 845
3%
Q4.23
916
916
vs 871
5%
Q1.24
932
932
vs 916
2%
Q2.24
897
897
vs 932
-4%
Q3.24
925
925
vs 897
3%
Q4.24
870
870
vs 925
-6%
Q1.25
873
873
vs 870
0%
Q2.25
894
894
vs 873
2%
Quote Panel
Key Metrics
Relative Strength
GSK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
Exane BNP Paribas
initialisePrevious: Not converted
2025-04-15
Now: Neutral
Deutsche Bank
downgradePrevious: Not converted
2024-11-15
Now: Hold
Guggenheim
downgradePrevious: Buy
2024-10-31
Now: Neutral
UBS
downgradePrevious: Not converted
2024-07-08
Now: Neutral